TB-500: Research Status, Evidence and Regulation
Status: Research only Evidence not yet graded
Last reviewed: Data retrieved:
Entry in preparation. Only verified fields are shown. Sections without verified data are hidden
until sources have been reviewed.
Quick facts
| Also known as | thymosin beta-4, thymosin beta 4 |
|---|---|
| Category | Tissue repair (research) |
| Research status | Research only |
| Overall evidence level | Evidence not yet graded |
Clinical trials snapshot
- Registered studies
- 18
- Most advanced phase
- Phase 3
- Recruiting or not yet recruiting
- 3
- Most recent start
- 2026-05-18
- Most frequent lead sponsor
- ReGenTree, LLC (6)
- Most common status
- Completed
Source: ClinicalTrials.gov, retrieved . Registry searches by name may miss studies that use other identifiers.
Related
Changelog
- — Entry skeleton created.
Last reviewed: Data retrieved: